Evidence map›Paper›PMID 30030567›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2018

MicroRNA-34a targets sirtuin 1 and leads to diabetes-induced testicular apoptotic cell death.

Dan Jiao, Huan Zhang, Ziping Jiang, Wenlin Huang, Zhuo Liu, Zhaohui Wang, Yonggang Wang, Hao Wu

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Dan JiaoDepartment of Ultrasound, China-Japan Union Hospital of Jilin University, 126 Xiantai St., Changchun, 130033, Jilin, China.
Huan ZhangOperating Theater, China-Japan Union Hospital of Jilin University, 126 Xiantai St., Changchun, 130033, Jilin, China.
Ziping JiangDepartment of Hand and Foot Surgery, The First Hospital of Jilin University, 71 Xinmin St., Changchun, 130021, Jilin, China.
Wenlin HuangSchool of Science and Technology, Georgia Gwinnett College, Lawrenceville, GA, 30043, USA.
Zhuo LiuCenter of Reproductive Medicine, Affiliated Hospital of Beihua University, 12 Jiefang Rd., Jilin, 132000, Jilin, China.
Zhaohui WangDepartment of Acupuncture and Tuina, Changchun University of Chinese Medicine, 1035 Boshuo Rd., Changchun, 130117, Jilin, China.
Yonggang WangDepartment of Urology, China-Japan Union Hospital of Jilin University, 126 Xiantai St.,, Changchun, 130033, Jilin, China. wangyongg@jlu.edu.cn.
Hao WuDepartment of Hand and Foot Surgery, The First Hospital of Jilin University, 71 Xinmin St., Changchun, 130021, Jilin, China. wuhaobaha@jlu.edu.cn.ORCID 0000-0001-5738-4015
Union Hospital · CNJilin University · CNBeihua University · CNChangchun University of Chinese Medicine · CNGwinnett College · US

Funding

National Natural Science Foundation of China 81600573National Natural Science Foundation of China 81774393Natural Science Foundation of Jilin Province 20160101117JCNatural Science Foundation of Jilin Province 2018SCZWSZX-045Natural Science Foundation of Jilin Province SCZSY201620Norman Bethune Program of Jilin University 2015438
6 · The paper itself

Abstract

Testicular apoptotic cell death (TACD) contributes to diabetes mellitus (DM)-induced male infertility. MicroRNA-34a (miR-34a) is a pro-apoptotic RNA that targets sirtuin 1 (SIRT1) which provides protection against complications of (DM). However, the specific role of miR-34a in (DM)-induced TACD is unknown. MiR-34a targets Sirt1 mRNA, resulting in apoptosis. However, whether or not SIRT1 is a major target of miR-34a in (DM)-induced TACD is unclear. The present study aimed to define the role of miR-34a/SIRT1 in (DM)-induced TACD. C57BL/6 male mice were induced to (DM) by streptozotocin, for a period of 24 weeks. The expression of miR-34a and Sirt1 as well as apoptotic cell death was determined in the testes of the non-diabetic, diabetic, and the miR-34a-specific inhibitor (miR-34a-I)-treated diabetic mice. In addition, the novel SIRT1 activator SRT2104 was delivered to the mice to determine the role of SIRT1 in DM-induced TACD. The diabetic mice developed remarkable testicular oxidative stress, endoplasmic reticulum stress, and apoptotic cell death, the effects of which were significantly and similarly attenuated by both miR-34a-I and SRT2104. Mechanistically, the DM-induced testicular elevation of miR-34a and the decrease in SIRT1 protein were markedly prevented by both miR-34a-I and SRT2104, to a similar extent. The present study demonstrates a critical role of miR-34a/SIRT1 in DM-induced TACD, providing miR-34a inhibition and SIRT1 activation as novel strategies in clinical management of DM-induced male infertility. KEY MESSAGES: MiR-34a mediates diabetes-induced TACD via inhibition of SIRT1. The novel SIRT1 activator SRT2104 attenuates diabetes-induced TACD. MiR-34a inhibition activates SIRT1 and prevents diabetes-induced TACD.

Indexed as

Gene Expression RegulationRNA InterferenceAnimalsApoptosisCells, CulturedDiabetes Mellitus, ExperimentalEndoplasmic Reticulum StressImmunohistochemistryMaleMiceMicroRNAsOrgan SizeOxidative StressSignal TransductionSirtuin 1Sperm CountMicroRNAsMIRN34a microRNA, mouseSirtuin 1ApoptosisDiabetesMiR-34aSIRT1Testis

Identifiers

PMID30030567
OpenAlexW2884263992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.